Royal Bank Of Canada Biodesix Inc Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.21 - $1.71 $183 - $259	152 New	152 $0
Q2 2022 Aug 15, 2022	SELL	$1.32 - $2.12 $1,141 - $1,833	-865 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.69 - $5.81 $3,772 - $12,967	-2,232 Reduced 72.07%	865 $1,000
Q4 2021 Feb 14, 2022	BUY	$4.09 - $8.67 $6,045 - $12,814	1,478 Added 91.29%	3,097 $16,000
Q3 2021 Nov 15, 2021	BUY	$6.6 - $12.78 $5,141 - $9,955	779 Added 92.74%	1,619 $13,000
Q2 2021 Aug 16, 2021	BUY	$12.14 - $20.35 $10,197 - $17,094	840 New	840 $11,000

62.3M

2.6K

10.1K

Ticker BDSX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 39,982,000
Market Cap $55.2M
Description
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.